Skip to main content
Equibles

SAN · Sanofi · Financials

Use SAN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SAN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
70.6100 EUR +0.6200 (+0.89%) At close · Oct 6
Rebalance outlook locked

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →

Browse captured authority reports and their original financial labels

Revenue
43.63B +6.2%
FY2025 Revenue FY2023–FY2025
Net Income
7.81B +40.5%
FY2025 Net Income FY2015–FY2025
Gross Margin
77.17% +1.5pp
FY2025 Gross Margin FY2023–FY2025
Operating Margin
14.54% -3.1pp
FY2025 Operating Margin FY2023–FY2025
Diluted EPS
6.37 +43.8%
FY2025 Diluted EPS FY2015–FY2025
Operating Cash Flow
10.75B +18.4%
FY2025 Operating Cash Flow FY2015–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015
EUR 13.05B 13.21B 12.63B 11.88B 12.26B 12.16B 11.98B 11.44B 11.61B 10.7B 10.92B
EUR 33.67B 31.08B 28.99B 28.68B 26.92B 25.21B 25.65B 24.24B 24.61B 24B 23.94B
EUR 7.84B 7.39B 6.51B 6.5B 5.69B 5.53B 6.02B 5.89B 5.47B 5.17B 5.08B
EUR 6.34B 7.25B 6.96B 10.16B 8.13B 14.11B 3.05B 4.68B 5.8B 6.53B 5.62B
EUR 563M 1.07B 1.29B 430M 368M 388M 440M 435M 420M 924M 559M
EUR 1.04B 1.2B 1.02B 1.91B 1.56B 1.81B 121M 481M 1.72B 1.33B 709M
EUR 7.81B 5.56B 5.4B 8.37B 6.22B 12.29B 2.75B 4.31B 8.42B 4.71B 4.29B
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2015–FY2025: 15.59B in buybacks, 13.93B in dividends.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Borrowings 2025-12-31 EUR 18,702,000,000 20-F filed 2026-02-17
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current borrowings, including current portion of noncurrent borrowings
EUR 4,342,000,000
Noncurrent long-term borrowings
EUR 14,248,000,000
Lease liabilities 2025-12-31 EUR 1,739,000,000 20-F filed 2026-02-17
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current lease liabilities
EUR 272,000,000
Noncurrent lease liabilities
EUR 1,467,000,000
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.